Atlas Trials

Bortezomib and Topotecan Hydrochloride in Treating Patients With Advanced Solid Tumors

Clinical trial NCT00541359 · COMPLETED

Trial details

NCT number
NCT00541359
Sponsor
City of Hope Medical Center
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Unspecified Adult Solid Tumor, Protocol Specific
Start date
2004-01-01
Primary completion
2011-06-01
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.